The respective model repository can be found in:
https://github.com/Open-Systems-Pharmacology/Erythromycin-Midazolam-DDI

The erythromycin-midazolam interaction was evaluated using five clinical DDI studies quantifying the interaction following nine different dosing regimens ([Carls 2014](#4-References), [Okudaira 2007](#4-References), [Olkkola 1993](#4-References), [Swart 2002](#4-References), [Zimmermann 1996](#4-References)).



| Enzyme | Perpetrator / victim     | Study design                                                 | Clinical study                   |
| ------ | ------------------------ | ------------------------------------------------------------ | -------------------------------- |
| CYP3A4 | Erythromycin / midazolam | Erythromycin: 250 mg po single dose (filmcoated tablet containing erythromycin stearate)<br />Midazolam: 0.03 mg po single dose, 1 hour after erythromycin dose | [Carls 2014](#4-References)      |
| CYP3A4 | Erythromycin / midazolam | Erythromycin: 1000 mg single dose (filmcoated tablet containing erythromycin stearate)<br />Midazolam: 0.03 mg po single dose, 1 hour after erythromycin dose | [Carls 2014](#4-References)      |
| CYP3A4 | Erythromycin / midazolam | Erythromycin: 200 mg po four times daily for 7 days (filmcoated tablet containing erythromycin stearate)<br />Midazolam: 2.5 mg po single dose, 1 hour after the 5<sup>th</sup> erythromycin dose | [Okudaira 2007](#4-References)   |
| CYP3A4 | Erythromycin / midazolam | Erythromycin: 200 mg po four times daily for 7 days (filmcoated tablet containing erythromycin stearate)<br />Midazolam: 2.5 mg po single dose, 1 hour after the 13<sup>th</sup> erythromycin dose | [Okudaira 2007](#4-References)   |
| CYP3A4 | Erythromycin / midazolam | Erythromycin: 200 mg po four times daily for 7 days (filmcoated tablet containing erythromycin stearate)<br />Midazolam: 2.5 mg po single dose, 1 hour after the 25<sup>th</sup> erythromycin dose | [Okudaira 2007](#4-References)   |
| CYP3A4 | Erythromycin / midazolam | Erythromycin: 500 mg po TID for 6 days (enteric coated tablet containing erythromycin as free base)<br />Midazolam: 0.05 mg/kg iv single dose, 2 hours after the 17<sup>th</sup> erythromycin dose | [Olkkola 1993](#4-References)    |
| CYP3A4 | Erythromycin / midazolam | Erythromycin: 500 mg po TID for 6 days (enteric coated tablet containing erythromycin as free base)<br />Midazolam: 15 mg po single dose, 2 hours after the 17<sup>th</sup> erythromycin dose | [Olkkola 1993](#4-References)    |
| CYP3A4 | Erythromycin / midazolam | Erythromycin: 500 mg po QID for 5 days (filmcoated tablet containing erythromycin stearate)<br />Midazolam: 0.075 mg/kg mg iv single dose, together with the 96<sup>th</sup> erythromycin dose | [Swart 2002](#4-References)      |
| CYP3A4 | Erythromycin / midazolam | Erythromycin: 500 mg po TID for 5 days (filmcoated tablet containing erythromycin stearate)<br />Midazolam: 0.8 mg po single dose, 1.5 hours after the 13<sup>th</sup> erythromycin dose | [Zimmermann 1996](#4-References) |

